Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Safety and Effectiveness of Apidra in Combination With Basal Insulin in Patients With Type 1 and 2 Diabetes Mellitus.

Trial Profile

Study of Safety and Effectiveness of Apidra in Combination With Basal Insulin in Patients With Type 1 and 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Insulin glulisine (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SCALE
  • Sponsors Sanofi
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 25 Feb 2009 Actual patient numbers (188) added as reported by ClinicalTrials.gov.
    • 16 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top